Markers of inflammation in periodontal diseases

Central-European Journal of Immunology

Volumn 38, Issue 3, 2013, Pages 363-366

  Nȩdzi Góra, Małgorzata ^a   Kostrzewa Janicka, Jolanta ^a   Górska, Renata ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Inflammation; Markers; Periodontitis

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL ENZYME; BACTERIAL TOXIN; BACTERIUM LIPOPOLYSACCHARIDE; C REACTIVE PROTEIN; ELASTASE; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKOTRIENE; NEUTROPHIL COLLAGENASE; PROSTAGLANDIN; PROSTAGLANDIN E2;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; ALVEOLAR BONE LOSS; ARTICLE; BACTERIAL VIRULENCE; CHEMOTAXIS; CHRONIC PERIODONTITIS; EIKENELLA CORRODENS; GINGIVITIS; HUMAN; IMMUNOREGULATION; INFLAMMATION; NEUTROPHIL; OSTEOLYSIS; PATHOGENESIS; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTITIS; PERIODONTIUM; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; SALIVA ANALYSIS; TANNERELLA FORSYTHENSIS; TOOTH PLAQUE; TREPONEMA DENTICOLA;

EID: 84889582291     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2013.37746     Document Type: Article

References (31)

1. Sheiham A, Netuveli GS (2002): Periodontal diseases in Europe. Periodontol 29: 104-121.
2. Górska, Pietruszka M, Dembowska E, Wysokińska-Miszczuk J, et al. (2012): Czȩstość wystȩpowania chorób przyzȩbia u osób w wieku 35-44 lat w populacji dużych aglomeracji miejskich. Dent Med Probl 49: 19-27.
3. Socransky SS, Haffajee AD, Cugini MA (1998): Microbial complexes in subgingival plaque. J Clin Periodontol 25: 134-144.
4. Page RC (1991): The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 26 (3 Pt 2): 230-242.
5. Joshipura KJ, Wand HC, Merchant AT, Rimm EB (2004): Periodontal disease and biomarkers related to cardiovascular disease. J Dent Res 83: 151-155.
6. D'Aiuto F, Parkar M, Andreou G, et al. (2004): Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83: 156-160.
7. Górska R, Nedzi-Góra M (2006): The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis. Arch Immunol Ther Exp (Warsz) 54: 419-426.
8. Korostoff JM, Wang JF, Sarment DP, et al. (2000): Analysis of in situ protease activity in chronic adult periodontitis patients: expression of activated MMP-2 and a 40 kDa serine protease. J Periodontol 71: 353-360.
9. Kuźmiński A, Przybyszewski M, Graczyk M, Kartuzi Z (2012): The role of extracellular matrix metalloproteinases and their inhibitors in allergic diseases. Postep Derm Alergol 29: 384-389.
10. Masada MP, Persson R, Kenney JS, et al. (1990): Measurement of interleukin-1 alpha and -1 beta in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. J Periodontal Res 25: 156-163.
11. Hou LT, Liu CM, Rossomando EF (1995): Crevicular interleukin-1 beta in moderate and severe periodontitis patients and the effect of phase I periodontal treatment. J Clin Periodontol 22: 162-167.
12. Reinhardt RA, Masada MP, Kaldahl WB, et al. (1993): Gingival fluid IL-1 and IL-6 levels in refractory periodontitis. J Clin Periodontol 20: 225-231.
13. Preiss DS, Meyle J (1994): Interleukin-1 beta concentration of gingival crevicular fluid. J Periodontol 65: 423-428.
14. Tsai CC, Ho YP, Chen CC (1995): Levels of interleukin-1 beta and interleukin-8 in gingival crevicular fluids in adult periodontitis. J Periodontol 66: 852-859.
15. Ishihara Y, Nishihara T, Kuroyanagi T, et al. (1997): Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodontal Res 32: 524-529.
16. Engebretson SP, Grbic JT, Singer R, Lamster IB (2002): GCF IL-1beta profiles in periodontal disease. J Clin Periodontol 29: 48-53.
17. Atilla G, Sorsa T, Rönka H, Emingil G (2001): Matrix metalloproteinases (MMP-8 and -9) and neutrophil elastase in gingival crevicular fluid of cyclosporin-treated patients. J Periodontol 72: 354-360.
18. Chen HY, Cox SW, Eley BM, et al. (2000): Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients. J Clin Periodontol 27: 366-369.
19. Eley BM, Cox SW (1992): Correlation of gingival crevicular fluid proteases with clinical and radiological measurements of periodontal attachment loss. J Dent 20: 90-99.
20. Cox SW, Eley BM (1992): Cathepsin B/L-, elastase-, tryptase, trypsin- and dipeptidyl peptidase IV-like activities in gingival crevicular fluid. Acomparison of levels before and after basic periodontal treatment of chronic periodontitis patients. J Clin Periodontol 19: 333-339.
21. Palcanis KG, Larjava IK, Wells BR, et al. (1992): Elastase as an indicator of periodontal disease progression. J Periodontol 63: 237-242.
22. Armitage GC, Jeffcoat MK, Chadwick DE, et al. (1994): Longitudinal evaluation of elastase as a marker for the progression of periodontitis. J Periodontol 65: 120-128.
23. Meyle J, Zell S, Brecx M, Heller W (1992): Influence of oral hygiene on elastase concentration of gingival crevicular fluid. J Periodontal Res 27: 226-231.
24. Jin LJ, Söder PO, Leung WK, et al. (1999): Granulocyte elastase activity and PGE2 levels in gingival crevicular fluid in relation to the presence of subgingival periodontopathogens in subjects with untreated adult periodontitis. J Clin Periodontol 26: 531-540.
25. Söder B, Jin LJ, Wickholm S (2002): Granulocyte elastase, matrix metalloproteinase-8 and prostaglandin E2 in gingival crevicular fluid in matched clinical sites in smokers and non-smokers with persistent periodontitis. J Clin Periodontol 29: 384-391.
26. Offenbacher S, Collins JG, Heasman PA (1993): Diagnostic potential of host response mediators. Adv Dent Res 7: 175-181.
27. Heasman PA, Collins JG, Offenbacher S (1993): Changes in crevicular fluid levels of interleukin-1 beta, leukotriene B4, prostaglandin E2, thromboxane B2 and tumour necrosis factor alpha in experimental gingivitis in humans. J Periodontal Res 28: 241-247.
28. Offenbacher S, Heasman PA, Collins JG (1993): Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol 64 (5 Suppl): 432-444.
29. Offenbacher S, Odle BM, Van Dyke TE (1986): The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodontal Res 21: 101-112.
30. Uitto VJ, Suomalainen K, Sorsa T (1990): Salivary collagenase. Origin, characteristics and relationship to periodontal health. J Periodontal Res 25: 135-142.
31. Gangbar S, Overall CM, McCulloch CA, Sodek J (1990): Identification of polymorphonuclear leukocyte collagenase and gelatinase activities in mouthrinse samples: correlation with periodontal disease activity in adult and juvenile periodontitis. J Periodontal Res 25: 257-267.